Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
April 05 2021 - 7:05AM
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical
company dedicated to developing and delivering treatments that
restore and preserve vision for people with serious back of the eye
diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief
Medical Officer and Chief Development Officer, will present at two
upcoming virtual conferences in April 2021:
Needham Virtual Healthcare
Conference Monday, April 12, 2021 at 12:45 p.m. ET
- The live and archived Needham
Virtual Healthcare Conference presentation webcast may be accessed
on the Clearside website under the Investors section: Events and
Presentations.
Wet AMD & DME Drug Development
Summit Wednesday, April 14, 2021Event details are
available on the conference website.
- 10:45 a.m. ET - Panel Discussion:
Ending the Burden of Monthly Treatments – Mechanisms to Increasing
the Durability & Accessibility of Wet AMD & DME
Therapeutics
- 1:40 p.m. ET - Suprachoroidal Drug
Delivery & CLS-AX: A Potential Solution for Treatment
Burden
- 2:55 p.m. ET - Chair Led Q&A:
Making Strides Forward in Drug Delivery & Dosing
About Clearside Biomedical
Clearside Biomedical, Inc. is a
biopharmaceutical company dedicated to developing and delivering
treatments that restore and preserve vision for people with serious
back of the eye diseases. Clearside’s proprietary SCS
Microinjector® targeting the suprachoroidal space (SCS®) offers
unique access to the macula, retina and choroid where
sight-threatening disease often occurs. The Company’s SCS injection
platform is an inherently flexible, in-office, non-surgical
procedure, intended to provide targeted delivery to the site of
disease and to work with both established and new formulations of
medications. For more information, please visit
www.clearsidebio.com.
Investor and Media Contacts:
Jenny Kobin Remy Bernarda ir@clearsidebio.com(678) 430-8206
Source: Clearside Biomedical, Inc.
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Sep 2023 to Sep 2024